insights_auto
Why is CT9 down 2.76%?
Dive Deeperchevron_right
CT9:FRA
Cardiol Therapeutics Inc
€1.13
arrow_downward
-2.76%(-0.032) 1D
Oct 8, 8:03:01 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CT9...
Open
€1.13
High
€1.13
Low
€1.13
Mkt. cap
223.59M
Avg. vol.
2.00K
Volume
0.00
52-wk high
€1.95
52-wk low
€0.73
No. of employees
18
Open
€1.13
High
€1.13
Low
€1.13
Mkt. cap
223.59M
Avg. vol.
2.00K
Volume
0.00
52-wk high
€1.95
52-wk low
€0.73
No. of employees
18
News stories
From web sources and news partners
kalkine.ca
·
1 day ago
Cardiol Therapeutics Inc. Stock Under Pressure as Phase III Trial Transition and Cash Burn Weigh on Investor Sentiment
kalkine.ca
·
2 days ago
Why Is Cardiol Therapeutics Stock Down Today? Phase III Heart-Disease Data Keeps TSX:CRDL in Focus
kalkine.ca
·
2 days ago
Cardiol Therapeutics Stock Faces Downside Pressure as Biotech Sentiment Weakens
Kalkine Media
·
2 days ago
What Makes Cardiol Therapeutics (TSX:CRDL) A Stock To Watch?
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersOakville, Ontario, Canada
SectorPharmaceutical industry
Websitecardiolrx.com